J. P. Moreau

Université de franche-comté — France

Medicine · Health Sciences

11h-index1.2kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroendocrine Tumor Research Advances(11), Pituitary Gland Disorders and Treatments(7), Neuroblastoma Research and Treatments(5), Growth Hormone and Insulin-like Growth Factors(4), Mollusks and Parasites Studies(3)

Publications22 total

Intérêt du lanréotide dans le traitement du carcinome de Merckel métastatique
Annales de Dermatologie et de Vénéréologie·2015· 1 cited
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy
European Journal of Endocrinology·2005· 147 citedOpen Access
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide.
PubMed·2005· 70 cited
Somatostatin receptor subtypes: targeting functional and therapeutic specificity.
PubMed·2002· 17 cited
BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas1
The Journal of Clinical Endocrinology & Metabolism·2001· 167 citedOpen Access
Human Somatostatin Receptor Subtypes in Acromegaly: Distinct Patterns of Messenger Ribonucleic Acid Expression and Hormone Suppression Identify Different Tumoral Phenotypes<sup>1</sup>
The Journal of Clinical Endocrinology & Metabolism·2000· 153 cited
Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas<sup>1</sup>
The Journal of Clinical Endocrinology & Metabolism·1999· 106 citedOpen Access
Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition
British Journal of Cancer·1997· 77 citedOpen Access
Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Molecular Pharmacology·1993· 281 citedOpen Access
Antitumoral Activity of Gastrin-Releasing Peptide Analogues on Small-Cell Lung Cancer Xenografts
Beiträge zur Onkologie/Contributions to oncology·1992· 1 cited
BIM 23014, a Somatostatin Analogue, Inhibits the Growth of Two Rat Breast Cancer Lines In Vivo
Beiträge zur Onkologie/Contributions to oncology·1992· 4 cited
Bradykinin‐antagonists: Therapeutic perspectives
Drug Development Research·1989· 34 citedOpen Access
Progress in the Development of Competitive Bombesin Antagonists
Annals of the New York Academy of Sciences·1988· 5 cited
Receptor-selective somatostatin (SRIF) analogs
Peptides·1988· 7 cited
High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69)
Life Sciences·1988· 40 cited
Pharmacological studies of somatostatin and somatostatin-analogues: Therapeutic advances and perspectives
Life Sciences·1987· 65 cited
A case of angiostrongyliasis.
Medecine d'Afrique Noire·1980
Therapeutic activity of levamisole in Bancroftian filariasis. A follow-up control of microfilaraemia during 45 days after 12 days' treatment.
Medecine Tropicale·1975· 1 cited
[In vitro trials of diethylcarbamazine. I. Effect on microfilariae of Wuchereria bancrofti var. pacifica].
PubMed·1972· 2 cited
Survie <i>in vitro</i> des larves de troisième stade d’<i>Angiostrongylus cantonensis</i>
Annales de Parasitologie Humaine et Comparée·1972· 5 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Michael D. Culler(6), Alexandru Saveanu(5), Ginette Gunz(5), P Jaquet(5), A Enjalbert(4), F. Fina(3), L’Houcine Ouafik(3), John E. Taylor(3), D.H. Coy(3), William A. Murphy(2), J. E. Taylor(2), Henry Dufour(2), H. Dufour(2), F.V. DeFeudis(2), J Lagraulet(2), K Raynor(1), D.H. Coy(1), Kei Yasuda(1), G I Bell(1), Terry Reisine(1)